FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for People Aged 18 Years and Older
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- S&P 500, Nasdaq ease from record highs as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 11.29 -0.03 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.32 | 52 Week High | $9.23 | |||
| Open | $11.01 | 52 Week Low | $1.16 | |||
| Day High | $11.75 | P/E | N/A | |||
| Day Low | $10.90 | EPS | $-0.30 | |||
| Volume | 5,416,232 | |||||
